Mirum Pharmaceuticals (MIRM) Common Equity (2018 - 2026)
Mirum Pharmaceuticals' Common Equity was -$10.42 million in Q2 2026, compared with $255.16 million a year earlier.
Powered by 
Analysis
Mirum Pharmaceuticals (MIRM) Common Equity (2018 - 2026) Analysis & Trends
At the end of FY2025, Common Equity at Mirum Pharmaceuticals came in at $314.69 million, up 39.5% from FY2024.
- Common Equity shows a five-year compound annual growth rate of 12.8% (FY2020 to FY2025).
- In earlier years, Common Equity was $225.64 million in FY2024 (-9.3%), $248.67 million in FY2023 (+75.1%), $142.04 million in FY2022 (+18.2%) and $120.21 million in FY2021 (-30.1%).
- The Q2 2026 figure marks the lowest quarterly Common Equity since Q2 2019.
- Compared with a year earlier, Common Equity was higher in four of the last seven quarters, with growth averaging 8.2%.
- The best year-over-year quarter for Common Equity over five years was Q3 2022 (growth of 200.2%); the worst was Q3 2021 (a decline of 53.1%).
- Per Business Quant data, MIRM's Common Equity in the three quarters before Q2 2026 was $242.49 million (Q1 2026), $314.69 million (Q4 2025) and $292.05 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Mirum Pharmaceuticals | 5.70 Bn | 4.11 Bn | 145.90 Mn | -10.42 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -10.42 Mn |
| Mar 31, 2026 | 242.49 Mn |
| Dec 31, 2025 | 314.69 Mn |
| Sep 30, 2025 | 292.05 Mn |
| Jun 30, 2025 | 255.16 Mn |
| Mar 31, 2025 | 233.26 Mn |
| Dec 31, 2024 | 225.64 Mn |
| Sep 30, 2024 | 232.02 Mn |
| Jun 30, 2024 | 228.99 Mn |
| Mar 31, 2024 | 234.60 Mn |
| Dec 31, 2023 | 248.67 Mn |
| Sep 30, 2023 | 269.08 Mn |
| Jun 30, 2023 | 78.61 Mn |
| Mar 31, 2023 | 141.15 Mn |
| Dec 31, 2022 | 142.04 Mn |
| Sep 30, 2022 | 169.30 Mn |
| Jun 30, 2022 | 110.69 Mn |
| Mar 31, 2022 | 108.93 Mn |
| Dec 31, 2021 | 120.21 Mn |
| Sep 30, 2021 | 56.40 Mn |
API Access
Mirum Pharmaceuticals Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=MIRM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "MIRM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=MIRM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();